UK and EU Competition Currents February 2022
UK CMA continues to focus on competitor collusion to increase the prices of pharmaceuticals supplied to the UK NHS by imposing fines totaling £35 million on four pharmaceutical firms and their parent companies, EC withholds default interest from Deutsche Telekom and more.
United Kingdom United Kingdom National Health Service European Parliament Deutsche Telekom European Commission A European Commission
Source: natlawreview.com